3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
2
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pembrolizumab
18
Cisplatin
18
Cetuximab
13
Carboplatin
10
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
Docetaxel
8
Paclitaxel
7
Radiotherapy, Intensity-Modulated
6
Platinum
6
Nivolumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
dostarlimab
4
Radiotherapy
4
Immunoglobulin G
4
Fluorouracil
4
Disulfides
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
atezolizumab
3
Radiation
3
Bevacizumab
3
cemiplimab
2
amivantamab
2
abemaciclib
2
Taxes
2
Fulvestrant
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
duvelisib
×
30 days
×
Clear all
No trials found.